187 related articles for article (PubMed ID: 35331716)
1. Predictors of QOL in Patients with Alopecia Areata.
Senna M; Ko J; Glashofer M; Walker C; Ball S; Edson-Heredia E; Zhu B; Shapiro J
J Invest Dermatol; 2022 Oct; 142(10):2646-2650.e3. PubMed ID: 35331716
[TBL] [Abstract][Full Text] [Related]
2. Physician- and Patient-Reported Severity and Quality of Life Impact of Alopecia Areata: Results from a Real-World Survey in Five European Countries.
Vañó-Galván S; Blume-Peytavi U; Farrant P; Reygagne P; Johansson E; Reed C; Marwaha S; Durand F; Piraccini BM
Dermatol Ther (Heidelb); 2023 Dec; 13(12):3121-3135. PubMed ID: 37889388
[TBL] [Abstract][Full Text] [Related]
3. Quality of life in patients with alopecia areata: a hospital-based cross-sectional study.
Janković S; Perić J; Maksimović N; Ćirković A; Marinković J; Janković J; Reljić V; Medenica L
J Eur Acad Dermatol Venereol; 2016 May; 30(5):840-6. PubMed ID: 26660721
[TBL] [Abstract][Full Text] [Related]
4. The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata.
Mesinkovska N; Craiglow B; Ball SG; Morrow P; Smith SG; Pierce E; Shapiro J
Dermatol Ther (Heidelb); 2023 Jul; 13(7):1503-1515. PubMed ID: 37289409
[TBL] [Abstract][Full Text] [Related]
5. Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomes.
Renert-Yuval Y; Correa da Rosa J; Garcet S; Pavel AB; Bares J; Chima M; Hawkes JE; Gilleaudeau P; Sullivan-Whalen M; Singer GK; Krueger JG; Guttman-Yassky E
Br J Dermatol; 2022 Oct; 187(4):539-547. PubMed ID: 35656793
[TBL] [Abstract][Full Text] [Related]
6. Patient-Reported Burden of Severe Alopecia Areata: First Results from the Multinational Alopecia Areata Unmet Need Survey.
Bewley A; Figueras-Nart I; Zhang J; Guerreiro M; Tietz N; Chtourou S; Durand F; Blume-Peytavi U
Clin Cosmet Investig Dermatol; 2024; 17():751-761. PubMed ID: 38566887
[TBL] [Abstract][Full Text] [Related]
7. Severity of disease and quality of life in parents of children with alopecia areata, totalis, and universalis: A prospective, cross-sectional study.
Putterman E; Patel DP; Andrade G; Harfmann KL; Hogeling M; Cheng CE; Goh C; Rogers RS; Castelo-Soccio L
J Am Acad Dermatol; 2019 May; 80(5):1389-1394. PubMed ID: 30633941
[TBL] [Abstract][Full Text] [Related]
8. Estimation of health utility values for alopecia areata.
Aggio D; Dixon C; Law EH; Randall R; Price T; Lloyd A
Qual Life Res; 2024 Jun; 33(6):1581-1592. PubMed ID: 38551802
[TBL] [Abstract][Full Text] [Related]
9. Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia.
Reid EE; Haley AC; Borovicka JH; Rademaker A; West DP; Colavincenzo M; Wickless H
J Am Acad Dermatol; 2012 Mar; 66(3):e97-102. PubMed ID: 21601948
[TBL] [Abstract][Full Text] [Related]
10. Reliability and validity of a measure to assess the health-related quality of life of women with alopecia areata.
Rees H; Wall D; Bokhari L; Asfour L; Sinclair R
Clin Exp Dermatol; 2023 Jun; 48(6):681-684. PubMed ID: 36806573
[TBL] [Abstract][Full Text] [Related]
11. HrQoL in hair loss-affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety.
Russo PM; Fino E; Mancini C; Mazzetti M; Starace M; Piraccini BM
J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):608-611. PubMed ID: 30394586
[TBL] [Abstract][Full Text] [Related]
12. A qualitative interview study to explore adolescents' experience of alopecia areata and the content validity of sign/symptom patient-reported outcome measures.
Macey J; Kitchen H; Aldhouse NVJ; Edson-Heredia E; Burge R; Prakash A; King BA; Mesinkovska N
Br J Dermatol; 2022 May; 186(5):849-860. PubMed ID: 34811721
[TBL] [Abstract][Full Text] [Related]
13. Illness perception in patients with androgenetic alopecia and alopecia areata in China.
Yu NL; Tan H; Song ZQ; Yang XC
J Psychosom Res; 2016 Jul; 86():1-6. PubMed ID: 27302539
[TBL] [Abstract][Full Text] [Related]
14. The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata.
Gelhorn HL; Cutts K; Edson-Heredia E; Wright P; Delozier A; Shapiro J; Senna M; Tosti A
Dermatol Ther (Heidelb); 2022 Apr; 12(4):989-997. PubMed ID: 35352323
[TBL] [Abstract][Full Text] [Related]
15. Assessing quality of life in Alopecia areata patients in China.
Qi S; Xu F; Sheng Y; Yang Q
Psychol Health Med; 2015; 20(1):97-102. PubMed ID: 24628099
[TBL] [Abstract][Full Text] [Related]
16. Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata.
Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Nunes FP; Dutronc Y; Mesinkovska N; Ko JM; King BA
Am J Clin Dermatol; 2020 Oct; 21(5):725-732. PubMed ID: 32803546
[TBL] [Abstract][Full Text] [Related]
17. The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials.
Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Nunes FP; Dutronc Y; Mesinkovska N; Ko JM; King BA
Br J Dermatol; 2020 Oct; 183(4):702-709. PubMed ID: 31970750
[TBL] [Abstract][Full Text] [Related]
18. Psychosocial impact of pediatric alopecia areata: A survey study.
Benton S; Bellefeuille G; Rypka K; Nguyen A; Raymond O; Gorbatenko-Roth K; Maguiness S; Hordinsky MK
Pediatr Dermatol; 2023 Mar; 40(2):312-314. PubMed ID: 36722625
[TBL] [Abstract][Full Text] [Related]
19. Patient and physician perspectives on alopecia areata: A real-world assessment of severity and burden in Japan.
Edson-Heredia E; Aranishi T; Isaka Y; Anderson P; Marwaha S; Piercy J
J Dermatol; 2022 Jun; 49(6):575-583. PubMed ID: 35343611
[TBL] [Abstract][Full Text] [Related]
20. 'The psychosocial burden of alopecia areata and androgenetica': a cross-sectional multicentre study among dermatological out-patients in 13 European countries.
Titeca G; Goudetsidis L; Francq B; Sampogna F; Gieler U; Tomas-Aragones L; Lien L; Jemec GBE; Misery L; Szabo C; Linder D; Evers AWM; Halvorsen JA; Balieva F; Szepietowski J; Romanov D; Marron SE; Altunay IK; Finlay AY; Salek SS; Kupfer J; Dalgard FJ; Poot F
J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):406-411. PubMed ID: 31465592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
